This analysis found no clear, net effect of ghrelin gene polymorphisms on cancer risk (Table 1), which is consistent with the conclusions of previous meta-analyses that evaluated the same genetic study data across ghrelin and ghrelin-receptor SNPs in patients with varied cancer types (Pabalan et al. 2014, Zhu et al. 2015). Here, GHRL is linked to cancer.